The results of this study suggest that ZCCHC4 is abnormally highly expressed in various digestive tract tumor tissues and may be a key regulator of CRC progression, and its knockdown can significantly inhibit tumor progression. Here, ZCCHC4 is linked to colorectal carcinoma.